Literature DB >> 10973516

Assessment of SNC 80 and naltrindole within a conditioned taste aversion design.

A C Hutchinson1, G R Simpson, J F Randall, X Zhang, S N Calderon, K C Rice, A L Riley.   

Abstract

Although compounds with relative selectivity for the mu and kappa opiate receptors subtypes have been reported to condition taste aversions, it is not known whether systemically administered delta compounds have the ability to produce aversions. To that end, female Long-Evans rats were adapted to water deprivation and were given pairings of a novel saccharin solution and various doses of the selective delta agonist SNC 80 (0.32-10.0 mg/kg; Experiment 1) or the selective delta antagonist naltrindole (1.0-18.0 mg/kg; Experiment 2). For comparison, the relatively selective mu agonist morphine (Experiment 1) and mu antagonist naloxone (Experiment 2) were assessed under identical conditions. Both SNC 80 (Experiment 1) and naltrindole (Experiment 2) were effective as unconditioned stimuli within this design, inducing dose-dependent taste aversions with repeated conditioning trials. Although at no dose did animals injected with SNC 80 differ from those injected with morphine, aversions induced by SNC 80 were acquired at a faster rate than those induced by morphine. Subjects injected with naloxone drank significantly less than those injected with naltrindole at the 10 mg/kg dose, and aversions induced by naloxone at 5.6 and 10 mg/kg were acquired at a faster rate than those induced by naltrindole. Although the basis for opioid agonist- and antagonist-induced taste aversions is not known, the differences between aversions induced by SNC 80 and naltrindole and those induced by morphine and naloxone, respectively, may be a function of their relative selectivity for specific opiate receptor subtypes.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10973516     DOI: 10.1016/s0091-3057(00)00278-1

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  3 in total

1.  Absence of delta -9-tetrahydrocannabinol dysphoric effects in dynorphin-deficient mice.

Authors:  A Zimmer; E Valjent; M Konig; A M Zimmer; P Robledo; H Hahn; O Valverde; R Maldonado
Journal:  J Neurosci       Date:  2001-12-01       Impact factor: 6.167

2.  Alterations of CXCR4 function in μ-opioid receptor-deficient glia.

Authors:  Silvia Burbassi; Rajarshi Sengupta; Olimpia Meucci
Journal:  Eur J Neurosci       Date:  2010-09-30       Impact factor: 3.386

3.  δ-Opioid receptor agonists inhibit migraine-related hyperalgesia, aversive state and cortical spreading depression in mice.

Authors:  Amynah A Pradhan; Monique L Smith; Jekaterina Zyuzin; Andrew Charles
Journal:  Br J Pharmacol       Date:  2014-05       Impact factor: 8.739

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.